Payment overview · 2025
General Payments
$192.19
9 reported records · 8 companies
Healthcare provider profile · identity verified
Ahmed Nazimuddin, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BURR RIDGE, IL · NPI 1710140975
Verified facts
What the public records show
CMS Open Payments records show Ahmed Nazimuddin, M.D. received $192.19 in general payments during 2025 across 9 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 20.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 6 associated products.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Ozempic by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Nuedexta by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 720 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $40.10 | 20.9% | 2 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $35.33 | 18.4% | 1 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $23.37 | 12.2% | 1 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $22.40 | 11.7% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $20.91 | 10.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $17.58 | 9.2% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $16.50 | 8.6% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $16.00 | 8.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $192.19 | 9 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC, Otsuka America Pharmaceutical, Inc. | $56.60 | 3 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $35.33 | 1 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $23.37 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $20.91 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $17.58 | 1 | 2025 |
Source payment records
|
|||||
| PAXLOVID Normalized: paxlovid |
Drug | PFIZER INC. | $16.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
15 | 15 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
720 | 95 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 980 | 195 |
| Levothyroxine Sodium | Levothyroxine Sodium | 834 | 118 |
| Amlodipine Besylate | Amlodipine Besylate | 829 | 125 |
| Eliquis | Apixaban | 720 | 95 |
| Escitalopram Oxalate | Escitalopram Oxalate | 688 | 75 |
| Furosemide | Furosemide | 564 | 101 |
| Quetiapine Fumarate | Quetiapine Fumarate | 558 | 54 |
| Memantine Hcl | Memantine Hcl | 510 | 61 |
| Metoprolol Tartrate | Metoprolol Tartrate | 497 | 90 |
| Losartan Potassium | Losartan Potassium | 453 | 76 |
| Donepezil Hcl | Donepezil Hcl | 441 | 55 |
| Pantoprazole Sodium | Pantoprazole Sodium | 435 | 79 |
| Potassium Chloride | Potassium Chloride | 432 | 78 |
| Gabapentin | Gabapentin | 426 | 92 |
| Lisinopril | Lisinopril | 418 | 73 |
| Metoprolol Succinate | Metoprolol Succinate | 386 | 75 |
| Trazodone Hcl | Trazodone Hcl | 370 | 59 |
| Omeprazole | Omeprazole | 358 | 56 |
| Sertraline Hcl | Sertraline Hcl | 324 | 49 |
| Tamsulosin Hcl | Tamsulosin Hcl | 323 | 69 |
| Clopidogrel | Clopidogrel Bisulfate | 254 | 46 |
| Mirtazapine | Mirtazapine | 253 | 41 |
| Metformin Hcl | Metformin Hcl | 252 | 54 |
| Duloxetine Hcl | Duloxetine Hcl | 234 | 33 |
| Simvastatin | Simvastatin | 225 | 35 |
| Finasteride | Finasteride | 217 | 32 |
| Famotidine | Famotidine | 207 | 33 |
| Carvedilol | Carvedilol | 194 | 42 |
| Pravastatin Sodium | Pravastatin Sodium | 146 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 145 | 47 |
| Torsemide | Torsemide | 132 | 32 |
| Citalopram Hbr | Citalopram Hydrobromide | 125 | 14 |
| Latanoprost | Latanoprost | 124 | 31 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 123 | 45 |
| Spironolactone | Spironolactone | 119 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 118 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 117 | 31 |
| Tramadol Hcl | Tramadol Hcl | 117 | 35 |
| Warfarin Sodium | Warfarin Sodium | 115 | 16 |
| Midodrine Hcl | Midodrine Hcl | 114 | 27 |
| Allopurinol | Allopurinol | 112 | 24 |
| Humalog Kwikpen U-100 | Insulin Lispro | 112 | 15 |
| Levetiracetam | Levetiracetam | 111 | 22 |
| Hydrochlorothiazide | Hydrochlorothiazide | 108 | 27 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 108 | 30 |
| Montelukast Sodium | Montelukast Sodium | 107 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 102 | 14 |
| Baclofen | Baclofen | 100 | 20 |
| Myrbetriq | Mirabegron | 100 | 15 |
| Lorazepam | Lorazepam | 98 | 19 |
| Buspirone Hcl | Buspirone Hcl | 97 | 18 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 96 | 14 |
| Risperidone | Risperidone | 93 | 17 |
| Alendronate Sodium | Alendronate Sodium | 91 | 20 |
| Olanzapine | Olanzapine | 90 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 88 | 20 |
| Lamotrigine | Lamotrigine | 88 | 13 |
| Alprazolam | Alprazolam | 84 | 21 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 83 | 37 |
| Fluticasone Propionate | Fluticasone Propionate | 81 | 27 |
| Cephalexin | Cephalexin | 77 | 51 |
| Xarelto | Rivaroxaban | 77 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 75 | 12 |
| Jardiance | Empagliflozin | 75 | 15 |
| Pregabalin | Pregabalin | 75 | 20 |
| Divalproex Sodium | Divalproex Sodium | 74 | 11 |
| Prednisone | Prednisone | 73 | 26 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 72 | 11 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 70 | 19 |
| Methenamine Hippurate | Methenamine Hippurate | 70 | 11 |
| Clonazepam | Clonazepam | 68 | 11 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 68 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 63 | 31 |
| Bupropion Xl | Bupropion Hcl | 63 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 61 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 59 | suppressed |
| Atenolol | Atenolol | 54 | suppressed |
| Timolol Maleate | Timolol Maleate | 54 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 52 | 32 |
| Ibuprofen | Ibuprofen | 50 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 49 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 47 | suppressed |
| Bumetanide | Bumetanide | 46 | 16 |
| Nystatin | Nystatin | 46 | 25 |
| Valsartan | Valsartan | 46 | suppressed |
| Nifedipine Er | Nifedipine | 44 | suppressed |
| Ezetimibe | Ezetimibe | 43 | 11 |
| Dapsone | Dapsone | 42 | suppressed |
| Sucralfate | Sucralfate | 41 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 40 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 40 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 40 | suppressed |
| Januvia | Sitagliptin Phosphate | 39 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 39 | suppressed |
| Amantadine | Amantadine Hcl | 37 | suppressed |
| Celecoxib | Celecoxib | 37 | suppressed |
| Gemtesa | Vibegron | 37 | suppressed |
| Aripiprazole | Aripiprazole | 35 | suppressed |
| Azithromycin | Azithromycin | 35 | 24 |
| Entresto | Sacubitril/Valsartan | 35 | suppressed |
| Irbesartan | Irbesartan | 35 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 35 | suppressed |
| Glipizide | Glipizide | 34 | 11 |
| Hydrocortisone | Hydrocortisone | 34 | 15 |
| Acetazolamide | Acetazolamide | 33 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 33 | suppressed |
| Glimepiride | Glimepiride | 32 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 32 | suppressed |
| Diazepam | Diazepam | 31 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 31 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 30 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 30 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 30 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 30 | suppressed |
| Amoxicillin | Amoxicillin | 29 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 29 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 29 | 14 |
| Benztropine Mesylate | Benztropine Mesylate | 28 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 11 |
| Flecainide Acetate | Flecainide Acetate | 28 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 28 | suppressed |
| Anastrozole | Anastrozole | 27 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 27 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Lacosamide | Lacosamide | 26 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 19 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | suppressed |
| Nystop | Nystatin | 25 | 19 |
| Clindamycin Hcl | Clindamycin Hcl | 24 | 15 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 24 | suppressed |
| Rivastigmine | Rivastigmine | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 23 | suppressed |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 23 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 23 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 22 | 11 |
| Enoxaparin Sodium | Enoxaparin Sodium | 22 | suppressed |
| Heparin Sodium | Heparin Sodium,porcine | 22 | suppressed |
| Levofloxacin | Levofloxacin | 22 | 13 |
| Loperamide | Loperamide Hcl | 22 | 12 |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Klayesta | Nystatin | 21 | 12 |
| Lactulose | Lactulose | 21 | suppressed |
| Rytary | Carbidopa/Levodopa | 21 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 21 | 18 |
| Azathioprine | Azathioprine | 20 | suppressed |
| Methotrexate | Methotrexate Sodium | 20 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 20 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 20 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 19 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 19 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Galantamine Er | Galantamine Hbr | 18 | suppressed |
| Kapspargo Sprinkle | Metoprolol Succinate | 18 | suppressed |
| Letrozole | Letrozole | 18 | suppressed |
| Novolog Flexpen | Insulin Aspart | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 17 | suppressed |
| Jantoven | Warfarin Sodium | 17 | suppressed |
| Klor-Con M20 | Potassium Chloride | 17 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 17 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 16 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 15 | 15 |
| Cinacalcet Hcl | Cinacalcet Hcl | 15 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 15 | suppressed |
| Erythromycin | Erythromycin Base | 15 | 11 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 15 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 15 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 15 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 14 | 14 |
| Clonidine | Clonidine | 14 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 14 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 14 | suppressed |
| Dulera | Mometasone/Formoterol | 14 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Calcium Acetate | Calcium Acetate | 13 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 13 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Folic Acid | Folic Acid | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | 12 |
| Minocycline Hcl | Minocycline Hcl | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Trulicity | Dulaglutide | 13 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Captopril | Captopril | 12 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Exemestane | Exemestane | 12 | suppressed |
| Levetiracetam Er | Levetiracetam | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Acetic Acid | Acetic Acid | 11 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 11 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Cefadroxil | Cefadroxil | 11 | suppressed |
| Entacapone | Entacapone | 11 | suppressed |
| Fentanyl | Fentanyl | 11 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 11 | suppressed |
| Meloxicam | Meloxicam | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 11 | suppressed |
| Thioridazine Hcl | Thioridazine Hcl | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
| Trueplus Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $192.19 · 9 records | Otsuka America Pharmaceutical, Inc. | AUSTEDO XR, Cologuard Collection Kit, FREESTYLE LIBRE 3, INGREZZA, PAXLOVID, REXULTI | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error